Dinner S - Search Results

1

Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab.

Badar T, Szabo A, Advani A, Wadleigh M, Arslan S, Khan MA, Aldoss I, Siebenaller C, Schultz E, Hefazi M, Shallis RM, Yurkiewicz I, Podoltsev N, Patel AA, Curran E, Balasubramanian S, Yang J, Mattison RJ, Burkart M, Dinner S, Liedtke M, Litzow MR, Atallah E. Badar T, et al. Among authors: dinner s. Blood Adv. 2020 May 26;4(10):2308-2316. doi: 10.1182/bloodadvances.2019001381. Blood Adv. 2020. PMID: 32453836 Free PMC article.

2

The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.

Dinner S, Witteles W, Witteles R, Lam A, Arai S, Lafayette R, George TI, Schrier SL, Liedtke M. Dinner S, et al. Br J Haematol. 2013 May;161(3):367-72. doi: 10.1111/bjh.12269. Epub 2013 Feb 23. Br J Haematol. 2013. PMID: 23432783 Free article. Clinical Trial.

3

Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement.

Dinner S, Witteles W, Afghahi A, Witteles R, Arai S, Lafayette R, Schrier SL, Liedtke M. Dinner S, et al. Haematologica. 2013 Oct;98(10):1593-9. doi: 10.3324/haematol.2013.084574. Epub 2013 May 28. Haematologica. 2013. PMID: 23716538 Free PMC article. Clinical Trial.

4

Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia.

Dinner S, Lee D, Liedtke M. Dinner S, et al. Leuk Lymphoma. 2014 Aug;55(8):1715-24. doi: 10.3109/10428194.2013.856428. Epub 2014 Apr 25. Leuk Lymphoma. 2014. PMID: 24251864 Review.

5

AL amyloidosis or multiple myeloma? An important distinction--response to Falk.

Dinner S, Liedtke M. Dinner S, et al. Br J Haematol. 2014 Mar;164(5):749-50. doi: 10.1111/bjh.12672. Epub 2013 Dec 17. Br J Haematol. 2014. PMID: 24344936 Free article. No abstract available.

6

Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia.

Liedtke M, Dunn T, Dinner S, Coutré SE, Berube C, Gotlib J, Patel S, Medeiros B. Liedtke M, et al. Among authors: dinner s. Leuk Res. 2014 Dec;38(12):1441-5. doi: 10.1016/j.leukres.2014.09.018. Epub 2014 Oct 6. Leuk Res. 2014. PMID: 25449689 Clinical Trial.

7

Targeting the mTOR Pathway in Leukemia.

Dinner S, Platanias LC. Dinner S, et al. J Cell Biochem. 2016 Aug;117(8):1745-52. doi: 10.1002/jcb.25559. Epub 2016 Apr 6. J Cell Biochem. 2016. PMID: 27018341 Review.

8

A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma.

Dunn TJ, Dinner S, Price E, Coutré SE, Gotlib J, Hao Y, Berube C, Medeiros BC, Liedtke M. Dunn TJ, et al. Among authors: dinner s. Br J Haematol. 2016 Apr;173(2):253-9. doi: 10.1111/bjh.13946. Epub 2016 Apr 4. Br J Haematol. 2016. PMID: 27040320 Free article. Clinical Trial.

9

A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma.

Dinner S, Dunn TJ, Price E, Coutré SE, Gotlib J, Berube C, Kaufman GP, Medeiros BC, Liedtke M. Dinner S, et al. Int J Hematol. 2018 Sep;108(3):267-273. doi: 10.1007/s12185-018-2468-5. Epub 2018 May 25. Int J Hematol. 2018. PMID: 29802551 Clinical Trial.

10

Future health of AYA survivors.

Burkart M, Sanford S, Dinner S, Sharp L, Kinahan K. Burkart M, et al. Among authors: dinner s. Pediatr Blood Cancer. 2019 Feb;66(2):e27516. doi: 10.1002/pbc.27516. Epub 2018 Oct 26. Pediatr Blood Cancer. 2019. PMID: 30362237 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters